Overview Fundamentals API Earnings EOD API Sample Code Pricing

Aurinia Pharmaceuticals Inc (AUPH NASDAQ) stock market data APIs

$5.66 -0.02(-0.4%) as of July 26, 2024
Price chart is built with Anychart

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc Financial Data Overview

5.68
5.66
-
5.7
5.59
4.71-12.38
807 M
143 M
191 M
-0.03
1.449
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AUPH',
Type: 'Common Stock',
Name: 'Aurinia Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BCRJM5',
ISIN: 'CA05156V1022',
CUSIP: '05156V102',
CIK: '1600620',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '1999-01-26',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Canadian',
IsDelisted: false,
}

Aurinia Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 191 M
  • EBITDA -47 000 000
  • Earnings Per Share -0.43
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Aurinia Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast -0.14

Get Aurinia Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com